Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence
Open Access
- 11 April 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 47 (4), 305-318
- https://doi.org/10.1007/s10928-020-09685-1
Abstract
The role of artificial intelligence (AI) in healthcare for pregnant women. To assess the role of AI in women’s health, discover gaps, and discuss the future of AI in maternal health. A systematic review of English articles using EMBASE, PubMed, and SCOPUS. Search terms included pregnancy and AI. Research articles and book chapters were included, while conference papers, editorials and notes were excluded from the review. Included papers focused on pregnancy and AI methods, and pertained to pharmacologic interventions. We identified 376 distinct studies from our queries. A final set of 31 papers were included for the review. Included papers represented a variety of pregnancy concerns and multidisciplinary applications of AI. Few studies relate to pregnancy, AI, and pharmacologics and therefore, we review carefully those studies. External validation of models and techniques described in the studies is limited, impeding on generalizability of the studies. Our review describes how AI has been applied to address maternal health, throughout the pregnancy process: preconception, prenatal, perinatal, and postnatal health concerns. However, there is a lack of research applying AI methods to understand how pharmacologic treatments affect pregnancy. We identify three areas where AI methods could be used to improve our understanding of pharmacological effects of pregnancy, including: (a) obtaining sound and reliable data from clinical records (15 studies), (b) designing optimized animal experiments to validate specific hypotheses (1 study) to (c) implementing decision support systems that inform decision-making (11 studies). The largest literature gap that we identified is with regards to using AI methods to optimize translational studies between animals and humans for pregnancy-related drug exposures.Keywords
Funding Information
- Perelman School of Medicine, University of Pennsylvania
This publication has 81 references indexed in Scilit:
- Integrating multiple ‘omics’ analyses identifies serological protein biomarkers for preeclampsiaBMC Medicine, 2013
- Translational Analysis of Mouse and Human Placental Protein and mRNA Reveals Distinct Molecular Pathologies in Human PreeclampsiaMolecular & Cellular Proteomics, 2011
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African AmericansBioinformatics, 2011
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureNew England Journal of Medicine, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Association of Intrauterine Exposure to Maternal Diabetes and Obesity With Type 2 Diabetes in YouthDiabetes Care, 2008
- Follow-Up Analysis of Pregnancies Complicated by HELLP SyndromeFetal Diagnosis and Therapy, 2006
- Interactive individualization: Patient counselling and drug information supported by knowledge systemsInternational Journal of Clinical Pharmacy, 1994
- Eliciting principles of hazard identification from expertsTeratology, 1990